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Inflammation is implicated in ischemic stroke and is involved in abnormal homeostasis.
Activation of the immune system leads to breakdown of the blood–brain barrier and,
thereby, infiltration of immune cells into the brain. Upon cerebral ischemia, infiltrated
macrophages and microglia (resident CNS immune cell) are activated, change their
phenotype to M1 or M2 based on the microenvironment, migrate toward damaged
tissue, and are involved in repair or damage. Those of M1 phenotype release
pro-inflammatory mediators, which are associated with tissue damage, while those
of M2 phenotype release anti-inflammatory mediators, which are related to tissue
recovery. Moreover, late inflammation continually stimulates immune cell infiltration and
leads to brain infarction. Therefore, regulation of M1/M2 phenotypes under persistent
inflammatory conditions after cerebral ischemia is important for brain repair. Herein, we
focus on apoptosis signal-regulating kinase 1 (ASK1), which is involved in apoptotic
cell death, brain infarction, and production of inflammatory mediators after cerebral
ischemia. We hypothesized that ASK1 is involved in the polarization of M1/M2
phenotype and the function of microglia and macrophage during the late stage of
ischemia/hypoxia. We investigated the effects of ASK1 in mice subjected to middle
cerebral artery occlusion and on BV2 microglia and RAW264.7 macrophage cell lines
subjected to oxygen-glucose deprivation. Our results showed that ASK1 silencing
effectively reduced Iba-1 or CD11b-positive cells in ischemic areas, suppressed
pro-inflammatory cytokines, and increased anti-inflammatory mediator levels at 7 days
after cerebral ischemia. In cultured microglia and macrophages, ASK1 inhibition,
induced by NQDI-1 drug, decreased the expression and release of M1-associated
factors and increased those of M2-associated factors after hypoxia/reperfusion (H/R).
At the gene level, ASK1 inhibition suppressed M1-associated genes and augmented
M2-associated genes. In gap closure assay, ASK1 inhibition reduced the migration
rate of microglia and macrophages after H/R. Taken together, our results provide new
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information that suggests ASK1 controls the polarization of M1/M2 and the function
of microglia and macrophage under sustained-inflammatory conditions. Regulation of
persistent inflammation via M1/M2 polarization by ASK1 is a novel strategy for repair
after ischemic stroke.
Keywords: apoptosis signal-regulating kinase 1 (ASK1), M1/M2 polarization, BV2 microglia cell line, RAW264.7
macrophage cell line, cerebral ischemia, hypoxia, late inflammation, ischemic stroke
INTRODUCTION
Inflammation is a key contributor to the pathophysiology of
ischemic stroke and is responsible for abnormal homeostasis
(Amantea et al., 2009; Denes et al., 2010; Iadecola and
Anrather, 2011). After ischemic insults, activation of the
immune system causes leakiness of the blood–brain barrier
(BBB), and immune cells such as macrophages, neutrophils
and leukocytes, infiltrate the lesion area via the disrupted
BBB (Amantea et al., 2009; Denes et al., 2010; Iadecola and
Anrather, 2011). Recruitment of immune cells results in initiation
of inflammatory processes in the brain parenchyma, which
include both tissue damage and repair (Fu et al., 2015).
Although inflammation is involved in all phases of ischemic
cascade (Iadecola and Anrather, 2011), late inflammation
in the brain, particularly after ischemic stroke, provokes
persistent immune cell recruitment and eventually aggravates
cerebral infarcts (Mena et al., 2004; Vogelgesang et al., 2014).
Therefore, regulation of late inflammation in ischemic stroke
is considered important to prevent development of subsequent
brain damage.
Once activated, microglia and infiltrated macrophages are able
to modify their morphology and function by switching between
M1 and M2 phenotypes (Tugal et al., 2013; Sica et al., 2015).
A classical (M1) polarized phenotype secretes Th1 cytokines and
pro-inflammatory mediators, such as interleukin (IL)-6, IL-1β,
and tumor necrosis factor (TNF)-α, which are involved in tissue
damage and prolong the neuro-inflammatory response (Tugal
et al., 2013; Sica et al., 2015; Qin et al., 2016). The alternative
(M2) phenotype releases Th2 cytokines and anti-inflammatory
mediators including transforming growth factor (TGF)-β, IL-4,
IL-10, and arginase (arg-1), which are associated with prevention
of inflammation, tissue repair, and neuro-protection (Tugal et al.,
2013; Sica et al., 2015; Qin et al., 2016). Although little is
known about the relationship between the chronic phase of
cerebral ischemia and immune cell phenotype modulating the
exaggerated inflammatory environment after ischemic stroke
via regulation of M1/M2 polarization could be a therapeutic
aim.
After I/R injury, the excessive accumulation of reactive
oxygen species (ROS) in cells induces oxidative stress and
subsequent damage (Cheon et al., 2013). ROS is a key player in
the pathophysiology of cerebral ischemia and ASK1 is known
as the initial responder of ROS (Kim et al., 2011; Cheon
et al., 2016b). Also, ASK1 is activated by various stimuli, such
as oxidative stress, calcium overload, and receptor-mediated
inflammatory signals (Hayakawa et al., 2006; Takeda et al.,
2008). After ischemic insult, ASK1 immediately promotes
intracellular signaling and induces apoptotic cell death, and
down-regulation of ASK1 diminishes cell death and cerebral
infarct. Previous studies demonstrated that ASK1 is associated
with brain edema (Kim et al., 2011; Song et al., 2015). In addition,
in mammals, ASK1 has been shown to modify innate immunity
and to be required for inflammatory response (Matsukawa
et al., 2004; Hayakawa et al., 2006; Takeda et al., 2008).
ASK1 deficiency leads to suppression of lipopolysaccharide
(LPS)-induced inflammatory cytokine production, such as IL-6,
IL-1β, and TNF-α in splenocytes and bone marrow-derived
dendritic cells (BMDCs). Also, in an LPS-induced sepsis
model, ASK1-deficient mice shows resistance against LPS injury
(Matsukawa et al., 2004; Takeda et al., 2008). Further, in primary
microglia cell culture, ASK1 is found to be closely related to TNF-
α and iNOS production (Katome et al., 2013). Class A scavenger
receptor suppresses M1 macrophages, thereby reducing IL-
6, IL-1β, and TNF-α in accordance with the dampening of
ASK1/p38/NF-κB pathway (Hu et al., 2011). In this study, we
focused on ASK1 and we hypothesized that ASK1 is likely
to affect inflammation via modulation of M1/M2 polarization
after I/R injury. Therefore, we examined whether ASK1 could
modulate polarization of microglia and macrophage in mice after
ischemic injury and in cultured BV2 microglia and RAW264.7
macrophage cell lines after hypoxic injury.
MATERIALS AND METHODS
Mouse Focal Cerebral Ischemia Model
All animal experiments in this study were conducted in
accordance by the Guide for the Care and Use of Laboratory
Animal Care and were approved by Institutional Animal Care
and Use Committee (IACUC) in Yonsei University. Mice were
provided free access to chow and water under a 12-h dark
and light cycle. A total of 52, adult male C57BL/6 mice
aged 8–12 weeks (Orient, Seongnam, Korea) were used in
this study. To mimic ischemic stroke, we utilized a middle
cerebral occlusion (MCAO) model. Anesthesia was induced with
5% isoflurane and maintained with 2% isoflurane in mixed
gas. Mice were placed onto a homeothermic blanket, and a
longitudinal incision was made along the midline of the neck.
MCA was occluded with a 6-0 blue nylon suture for 1 h
and mice were reperfused for 7 days. At 7 days after MCAO,
Zoletil mixture (30 mg/kg; active ingredient: Zolezepam and
Tiletamin; Virbac Laboratories, Carros, France) was injected
intraperitoneally. Mice were cardiac-perfused with saline, and
brains were isolated for immunohistochemistry and ELISA assay.
The mice were divided into three groups: normal group (control),
ischemia/reperfusion (I/R) group, and ischemia/reperfusion+ si-
ASK1 treated (I/R+si-ASK1) group.
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siRNA Experiment
ASK1-siRNA was purchased from Ambion [Austin, TX,
United States; sense, 5′-GCUGGUAAUUUAUACACuGtt-3′;
antisense, 5′-CAGUGUAUAAAUUACGAGCtt–3′; conc, 5 µM
(178.5–192.3 nM/g)] (Cheon et al., 2016b; Cho et al., 2016). Based
on a previous study, a 100-µl solution mixed with siPORTNeoFX
(Ambion) and ASK1-siRNA was administrated into the left
ventricle of the mice by an osmotic pump with a brain infusion
kit (Alzet, Cupertino, CA, United States) for 3 days before
MCAO. The osmotic pump was planted subcutaneously on the
dorsal side, and brain infusion cannula connected to the osmotic
pump was placed on the left ventricle (mediolateral 1.0 mm,
anteroposterior 0.2 mm, dorsoventral 3.0 mm). The hole in the
skull was made by using a drill (Cheon et al., 2016b; Cho et al.,
2016).
BV2 Microglia and RAW 264.7
Macrophage Cell Cultures
Murine brain microglia (BV2 cell line) were cultured with
RPMI 1640 (HycloneTM, GE Healthcare Life Sciences, Logan,
UT, United States) containing 10% fetal bovine serum (FBS,
GE Healthcare Life Sciences) and 1% penicillin-streptomycin
solution (Thermo Scientific, Waltham, MA, United States).
Murine macrophages (RAW 264.7cell line) were cultured with
DMEM high glucose cultured media (HycloneTM, GE Healthcare
Life Sciences) containing 10% FBS (GE Healthcare Life Sciences)
and 1% penicillin-streptomycin solution (Thermo Scientific) at
37◦C. The cultured cells were incubated in a humid atmosphere
under the presence of 5% CO2 at 37◦C.
Oxygen/Glucose Deprivation
To induce oxygen and glucose deprivation, microglia and
macrophage cultures were transferred to an anaerobic
chamber after being washed with phosphate buffer saline
(PBS). Transferred cells were then cultured in deoxygenated
glucose-free balanced solution (BSS0) containing 5.36 mM KCl,
0.81 mM NaH2PO4, 0.81 mM MgSO4, and116 mM NaCl, and
incubated for 4 h in a 37◦C anaerobic chamber. After 4 h, the
cells were washed with PBS, the cultured media was changed,
and cells were incubated for 24 h under the presence of 5% CO2
at 37◦C. To inhibit ASK1, the ASK1 inhibitor NQDI-1 drug
(600 nM, Tocris Bioscience, Bristol, United Kingdom) was used
in this study and was applied 1 h before hypoxia and 4 h during
hypoxia.
Immunofluorescence Staining
Mice were cardiac-perfused with 4% formaldehyde, and brains
specimens were fixed with 4% formaldehyde for 24 h. Fixed
brains were immersed in 30% sucrose for 2 days and then
frozen with OCT compound (Sakura Finetek Japan Co., Ltd.,
Tokyo, Japan) at −70◦C in a deep freezer. Frozen brain
tissues were sectioned coronally with a cryotome with 20-µm
thickness and onto coated slide glass. After drying the slide
at room temperature, sections were treated with Trion-X 100
(0.3%) for permeability over 1 h and treated blocking solution
[5% bovine serum albumin (BSA)] at room temperature for
1 h. After washing with PBS, primary antibodies such as
anti-Iba-1 (Abcam, Cambridge, United Kingdom), anti-CD11b
(Millipore, Bedford, MA, United States), anti-CD206 (Abcam),
and anti-ASK1 (Santa Cruz Biotechnology, Santa Cruz, CA,
United States) were incubated, respectively, overnight at 4◦C.
Secondary antibody conjugated FITC or Rhodamine (Jackson
ImmunoResearch Laboratories, West Grove, PA, United States)
was used and incubated for 1 h at room temperature after
washing with PBS. Slides were mounted with Vectashield with
DAPI (Vector Laboratories Inc., Burlingame, CA, United States).
The specimens were observed by using an LSM 700 confocal
microscope (Carl Zeiss, Thornwood, NY, United States) and
microscope (Olympus, Tokyo, Japan). Immunoreactivities for
CD11b, Iba-1, CD206, and ASK1 were measured using ImageJ
(ImageJ, Bethesda, MD, United States) and Zen 2010 software
(Carl Zeiss) by analyzing the mean intensities, which apply a
manual threshold above the background intensity. The mean
intensities were analyzed by average intensity, obtained from
three slice of each mouse. Three fields of the cortex, striatum, and
hippocampus were randomly chosen from each specimen.
Cresyl Violet Staining
Brains of mice were isolated and fixed with 4% formaldehyde and
sectioned coronally with a cryotome at a thickness of 20-µm.
Sectioned brains were stained with filtered cresyl violet acetate
(0.5%) (Sigma–Aldrich, St. Louis, MO, United States), which was
dissolved in 300 mL distilled water with 10% glacial acetic acid.
Slides were incubated with cresyl violet solution for 3 min at
room temperature and coverslipped with permanent mounting
medium (Vector Laboratories), and then, samples were observed
under a microscope (Olympus).
Enzyme-Linked Immunosorbent Assay
(ELISA)
To evaluated cytokine levels from tissue, BV2 microglia cell
line, BV2 microglial supernatants, RAW 264.7 macrophage cell
line and RAW264.7 macrophage supernatants, ELISA assays
were performed according to commercial protocols. Levels of
pro-inflammatory cytokines, such as IL-1β, IL-6, and TNF-
α, and anti-inflammatory cytokines including IL-10, were
measured. Samples were analyzed by High Sensitivity mouse IL-1
beta/IL-1F2, IL-6, TNF-alpha, and IL-10 Quantikine ELISA kits
(R&D systems, Minneapolis, MN, United States). Following the
manufacturer’s instructions, reagents and standards in the ELISA
kits were prepared, and prepared sample was added to each well
with assay diluents and incubated. After washing with wash buffer
for three times, samples were incubated with mouse IL-1β, IL-6,
TNF-α, or IL-10 conjugates for 2 h at room temperature. After
reactions completed, samples were read at a 450-nm wavelength
by an ELISA reader.
Real-Time-PCR
To evaluate M1 and M2 phenotypes, BV2 microglia and RAW
264.7 macrophage cell lines were collected from which total
RNA was extracted by using RNeasy R© Mini Kit (QIAGEN,
Austin, TX, United States). RNA concentration was assessed
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using NanoDrop R© ND-1000 (Thermo Scientific, NanoDrop
Technologies, Wilmington, DE, United States). Real-time
PCR was performed using the one-step SYBR PrimeScript
RT-PCR Kit II (Perfect Real Time) (Takara Bio Inc., JAPAN)
on an ABI StepOne Plus. PCR was performed in a total
reaction mixture volume of 20 µl, composed of One step
SYBR RT-PCR Buffer, PrimeScript 1 step Enzyme Mix 2,
ROX Reference Dye, each forward primer (100 nM), each
reverse primer (100 nM), and sample RNA diluted in RNase
Free dH2O. The RNA samples were used by 10-fold serial
dilution. The primers were as follows: TNF-α: Forward (F)
5′-ACGGCATGGATCTCAAAGAC-3′, Reverse (R) 5′-AGATAG
CAAATCGGCTGACG-3′, IL-1β: (F) 5′-TGTCTTGGCCGAGG
ACTAAGG-3′, (R) 5′-TGGGCTGGACTGTTTCTAATGC-3′,
IL-6: (F) 5′-TCCAGTTGCCTTCTTGGGAC-3′, (R) 5′-GTG
TAATTAAGCCTCCGACTTG-3′, iNOS: (F) 5′- CAGCTGG
GCTGTACAAACCTT-3′, (R) 5′-CATTGGAAGTGAAGCGTT
TCG-3′, Cxcl10: (F) 5′-GGATGGCTGTCCTAGCTCTG-3′, (R)
5′-TGAGCTAGGGAGGACAAGGA-3′, IL-10: (F) 5′-GCTCT
TACTGACTGGCATGAG-3′, (R) 5′-CGCAGCTCTAGGAGCA
TGTG-3′, Ym-1: (F) 5′-GGGCATACCTTTATCCTGAG-3′, (R)
5′-CCACTGAAGTCATCCATGTC-3′, ASK1: (F) 5′-AGGACGG
AGACTGTGAGGGT-3′, (R) 5′-GTCCTGCATAGACGATCC
CAT-3′, GAPDH: (F) 5′-CCATTTGCAGTGGCAAAG-3′, (R)
5′-CACCCCATTTGATGTTAGTG-3′. The standard curve and
melt curve analysis were used and cycling threshold (Ct) values
were normalized to Ct values of housekeeping gene. The values
were presented by relative quantity (RQ). The results were
analyzed by StepOnesoftware v2.3.
Gap Closure Assay
Microglia or macrophages were seeded in 60-mm dishes 1 day
prior to experimentation. A gap was made with a sterile, 1000-µl,
blue pipette tip, and dishes were washed with DPBS to remove cell
culture media and cell debris. Cultured cells underwent oxygen
and glucose deprivation for 4 h and were transferred to normal
culture media in a 37◦C anaerobic chamber. Cells were incubated
for 24 h in a 37◦C anaerobic chamber, and images were obtained
using inverted microscope with a digital camera (Leica, MC179,
Wetzlar, Germany).
Flow Cytometry Analysis of BV2
Microglia and RAW 264.7 Macrophage
Cell Lines
BV2 microglia and RAW264.7 macrophage cell line were
collected and washed with DPBS. FACS buffer [Dulbecco’s
Phosphate-Buffered Saline (PBS) with 2% Fetal Bovine Serum,
0.09% Sodium Azide] (BD PharmingenTM, BD Biosciences, San
Hose, CA, United States) were added to cells and incubated
for 10 min. Next, cells were centrifuged at 250 g for 3 min,
and the pellet was resuspended with 500 µl of FACS buffer.
Cells were blocked with mouse Fc blocking solution (1:50,
BD Biosciences) for 10 min on ice and centrifuged at 250 g
for 3 min at 4◦C. Cells were then stained with the following
antibodies: mouse anti-CD40-FITC (1:50 MACS Miltenyi Biotec,
Bergisch Gladbach, Germany) and mouse anti-CD206-PE (1:50,
BD PharmingenTM, BD biosciences) for 30 min on ice. Cell
suspensions were then filtered through a cell strainer with
a 40-µm nylon mesh. Cell fluorescence was acquired using
flow cytometry with a LSR II analyzer (BD PharmingenTM,
BD biosciences). Data were analyzed using FlowJo software,
version10 (FLOWJO, LLC, Ashland, OR, United States).
TUNEL Assay
Terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) assay was performed to evaluate DNA fragmentation.
We used TUNEL assay kit, purchased from Roche Diagnostics
(Indianapolis, IN, United States), and performed according to
the manufacturer’s manual. Counterstaining was performed with
propidium iodide (PI) (Sigma–Aldrich) and the number of
TUNEL-positive cells was counted in three 100 µm × 100 µm
squares of each specimen and expressed as the number of
TUNEL-positive cells square millimeter.
Statistical Analysis
Data are presented as the mean ± standard deviation (SD).
Statistical comparisons between the groups were assessed
with non-parametric Mann–Whitney test (Prism version 5.0
software, GraphPad Software, San Diego, CA, United States).
Statistical significance among groups was assigned to p-values less
than 0.05.
RESULTS
Increase in Microglia/Infiltrated
Macrophages Reduced in the Ischemic
Cortex and Striatum after ASK1 Silencing
The previous study showed that siRNA for ASK1 significantly
reduces ASK1 level (Kim et al., 2011; Cheon et al., 2016b).
In this study, we followed this method and confirmed
immunohistochemistry for ASK1 with/without administration of
siRNA for ASK1 at 7 days after I/R. We observed that ischemia-
induced ASK1 expression was efficiently reduced after ASK1
silencing (Supplementary Figure 1A). In addition, at 3 days after
I/R, we performed real-time PCR for ASK1. Upregulated ASK1
transcripts after I/R significantly diminished after ASK1 silencing
(Supplementary Figure 1B). Ischemic injury induces a functional
change in the brain and leads to cell death, the morphological
changes of which were observed. To observe cell morphology
after cerebral ischemia, we performed cresyl violet staining 7 days
after (I/R) (Figure 1A). As shown in Figure 1A, cell bodies
observed in the cortex and striatum in the I/R group were smaller
and thinner than those in the control group. After silencing
ASK1, we observed comparatively rounder and healthier cell
bodies, compared with those of the I/R group, at 7 days after
I/R. To examine microglia and infiltrated macrophages, we used
microglia and macrophage markers, such as Iba-1 and CD11b,
respectively (Figure 1B). In the control group, Iba-1-positive
and CD11b-positive cells were rarely observed in the cortex and
striatum. However, Iba-1-positive and CD11b-positive cells were
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FIGURE 1 | Decreased microglia and macrophage markers in the striatum and cortex, respectively, upon ASK1 silencing at 7 days after cerebral ischemia. (A) Cresyl
violet staining for cell histology in the cortex and striatum shows that I/R-induced cell loss was not detected at 7 days in the I/R+si-ASK1 group.
(B) Immunofluorescent staining for Iba-1 (green) and CD11b (red) in the cortex and striatum reveals that I/R-induced increase in Iba-1 or CD11b-positive cells were
reduced in the I/R+si-ASK1 group at 7 days. (C) The graph shows the relative fluorescent intensities for Iba-1 and CD11b in the striatum (n = 4). (D) The graph
indicates the relative fluorescent intensities for Iba-1 and CD11b in the cortex (n = 4). Values are means ± SD. Statistical comparisons between the groups were
assessed with non-parametric Mann–Whitney test (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs. I/R group). Statistical parameter (Supplementary Table 1). I/R,
ischemia/reperfusion.
densely expressed in the I/R group. After silencing ASK1, Iba-
1-positive and CD11b-positive cells decreased in the cortex and
striatum, respectively, despite ischemic injury. The graphs for
relative fluorescent intensity showed increased intensities for Iba-
1 and CD11b were efficiently decreased after silencing ASK1,
compared with the I/R group (Figures 1C,D). Therefore, our
data showed that ASK1 silencing results in reduced microglia and
macrophages in the ischemic cortex and striatum, respectively.
Statistical parameters were shown in Supplementary Table 1.
Enhanced Microglia/Infiltrated
Macrophages Eliminated in Ischemic
Hippocampus Tissue after ASK1
Silencing
In hippocampus specimens stained with cresyl violet, cells in
CA1 and CA3 were easily observed as violet-stained intact cell
bodies. However, I/R decreased violet-stained cells in the CA1
and CA3 regions after 7 days. In contrast, ASK1 silencing by
genetic manipulation inhibited the reduction of violet-stained
cells caused by I/R injury (Figure 2A). Also, we evaluated
the expression of Iba-1 and CD11b in the hippocampus, via
immunofluorescent staining at 7 days after I/R (Figure 2B). In
the control group, CA1 and CA3 regions of the hippocampus
displayed small amounts of Iba-1-positive and CD11b-positive
cells. In the I/R group, Iba-1-positive cells and CD11b-positive
cells were largely founded in the CA1 and CA3 regions of
the hippocampus. On the contrary, ASK1-silenced brain tissue
showed decreased levels of Iba-1 and CD11b expression in
CA1 and CA3, respectively. The graphs for relative fluorescent
intensity showed enhanced intensities for Iba-1 and CD11b
were efficiently diminished after silencing ASK1, compared with
the I/R group (Figures 2C,D). These results indicated that
ASK1 silencing leads to suppressed activation of microglia and
macrophages in the hippocampus. Statistical parameters were
shown in Supplementary Table 1.
Silencing ASK1 Diminishes
Pro-inflammatory and Increases
Anti-inflammatory Mediators in Ischemic
Brain Tissue
Several studies have demonstrated that microglia and
macrophages can release pro-inflammatory mediators, such
as IL-1β, IL-6, and TNF-α, under pathologic conditions. To
investigate whether ASK1 silencing can reduce the release of
pro-inflammatory cytokines, we assessed the expression there
in the ischemic hemisphere at 7 days after I/R using ELISA
(Figure 3). Our results showed that cerebral ischemia induced
upregulation of IL-6, TNF-α, and IL-1β significantly, when
compared with that of the control group. After silence of ASK1,
increased levels of IL-6, TNF-α, and IL-1β were efficiently
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FIGURE 2 | Reduced microglia and macrophage markers in the hippocampus upon silence of ASK1 at 7 days after cerebral ischemia. (A) Cresyl violet staining for
cell histology in the hippocampus shows that I/R-induced cell loss was not detected at 7 days in the I/R+si-ASK1 group. (B) Immunofluorescent staining for Iba-1
(green) and CD11b (red) in the hippocampus revealed that I/R-induced augmentation of Iba-1 or CD11b-positive cells was reduced in the I/R+si-ASK1 group at
7 days. (C) The graph shows the relative fluorescent intensities for Iba-1 and CD11b in the hippocampal CA1 region (n = 4). (D) The graph exhibits the relative
fluorescent intensities for Iba-1 and CD11b in the hippocampal CA3 region (n = 4). Values are mean ± SD. Statistical comparisons between the groups were
assessed with non-parametric Mann–Whitney test (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs. I/R group). Statistical parameter (Supplementary Table 1). I/R,
ischemia/reperfusion.
decreased in the ischemic hemisphere. Our ELISA data showed
that ASK1 silencing reduces the expression of pro-inflammatory
cytokines in the ischemic hemisphere (Figures 3A–C).
In addition, to examine whether ASK1 silencing can increase
anti-inflammatory mediators, we performed immunofluorescent
staining for CD206 (Figure 3D). Our results showed that
CD206-positive cells in the control group were not significantly
different between those in the I/R group; however, ASK1 silencing
increased CD206-positive cells in the striatum and cortex
(Figures 3D–G). To determine the effect of ASK1 on the cell
fate, we performed TUNEL assay to detect DNA fragmentation
at 7 days after I/R (Supplementary Figure 1C). The images and
graphs showed that increased the number of TUNEL-positive
cells in the striatum and cortex after I/R was efficiently reduced
after ASK1 silencing. Therefore, our data showed that ASK1
silencing suppresses M1 phenotype and increases M2 phenotype
in ischemic brain and reduces apoptotic cell death. Statistical
parameters were shown in Supplementary Table 1.
Inhibition of ASK1 Downregulates
Pro-inflammatory Mediators, but
Upregulates Anti-Inflammatory
Mediators in Cultured BV2 Microglia Cell
Line and Supernatants
To investigate the effects of ASK1 on function of microglia, we
performed single cell line cultures with BV2 cells and ELISA
assay of cells (Figures 4A–D) and supernatants (Figures 4E–H).
We used NQDI-1 drug in vitro to exclude effects of genetic
manipulation unlike in vivo experiments. To identify the release
of inflammatory mediators from BV2 microglia cell line, we
also assayed cytokine levels in BV2 microglial supernatants.
Our quantitative analysis showed that hypoxia/reperfusion (H/R)
upregulated M1 phenotypes, reflected as release of IL-6, TNF-α,
and IL-1β, both in BV2 microglia cell line (Figures 4A–C)
and in BV2 microglial supernatants (Figures 4E–G). After
treatment with NQDI-1 drug, an ASK1 inhibitor, the upregulated
M1 mediators were efficiently reduced despite H/R injury.
Although H/R could not alter IL-10 levels in BV2 microglia
cell line (Figure 4D), compared with the control, NQDI-1 drug
treatment upregulated secretion of IL-10 after H/R injury both
in BV2 microglia cell line (Figure 4D) and in BV2 microglial
supernatants (Figure 4H). Therefore, the results indicated that
inhibition of ASK1 suppresses M1 phenotype and activates
the alternative M2 phenotype in BV2 microglia cell line after
H/R injury. Statistical parameters were shown in Supplementary
Table 2.
Suppression of ASK1 Decreases
Pro-inflammatory Mediators, but
Increases Anti-Inflammatory Mediators
in Cultured RAW 264.7 Macrophage Cell
Line and Supernatants
To examine the effects of ASK1 on macrophage function,
we performed single cell line cultures with RAW 264.7 cells
and ELISA of cells and supernatants (Figure 5). Our results
suggested that H/R injury triggered expression of M1-related
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FIGURE 3 | Decreased pro-inflammatory and increased anti-inflammatory mediators in the ischemic brain by silencing of ASK1 at 7 days after cerebral ischemia.
The levels of (A) IL-6, (B) TNF-α, and (C) IL-1β in the hemisphere were assessed by ELISA at 7 days after I/R. I/R-induced upregulation of (A) IL-6, (B) TNF-α, and
(C) IL-1β was decreased in the I/R+si-ASK1 group at 7 days (n = 8). Immunofluorescent staining for CD206 was performed at 7 days after I/R (D,F). (D) The relative
intensity graph indicates CD206-positive cells were increased in the striatum (E) and cortex (G), compared with other groups (n = 4–5). Values are mean ± SD.
Statistical comparisons between the groups were assessed with non-parametric Mann–Whitney test (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs. I/R group). Statistical
parameter (Supplementary Table 1). I/R, ischemia/reperfusion.
mediators, such as IL-6, TNF-α, and IL-1β. However, suppression
of ASK1 significantly decreased M1 phenotypes in RAW 264.7
cell line (Figures 5A–C) and in supernatants (Figures 5E–G).
In addition, IL-10 levels were also increased after inhibition of
ASK1 in spite of H/R injury, as compared with control and H/R
injured macrophages, both in RAW 264.7 cell line (Figure 5D)
and in supernatants (Figure 5H). Therefore, our data showed
that inhibition of ASK1 reduces M1 phenotype and increases
M2 phenotype in RAW 264.7 macrophage cell line. Statistical
parameters were shown in Supplementary Table 2.
Inhibition of ASK1 Induces Transcription
of M2 Polarization in BV2 Microglia and
RAW 264.7 Macrophage Cell Lines
Genetic expression of M1 and M2 markers was quantified by
real-time PCR in BV2 microglia (Figure 6) and in RAW 264.7
macrophage cell lines (Figure 7). Similar to cytokine levels
evaluated by ELISA, the mRNA levels of M1 polarization-related
factors such as IL-1β, TNF-α, inducible nitric oxide (iNOS),
and CXCL10 were all significantly increased in BV2 microglia
cell line after H/R injury (Figures 6A–D), and those of M2
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FIGURE 4 | Downregulated pro-inflammatory cytokines and upregulated anti-inflammatory cytokines after inhibition of ASK1 in cultured BV2 microglia cell line and
supernatants. The levels of pro-inflammatory mediators, such as (A) IL-6, (B) TNF-α, and (C) IL-1β and the anti-inflammatory mediator (D) IL-10 were determined by
ELISA in BV2 cell line after H/R (4 h/24 h). Increased (A) IL-6 (7 repeats), (B) TNF-α (8 repeats), and (C) IL-1β (8 repeats) levels after H/R were reduced and (D) IL-10
(4 repeats) levels were increased by inhibition of ASK1 in BV2 cell line. The levels of (E) IL-6, (F) TNF-α, and (G) IL-1β and the anti-inflammatory mediator (H) IL-10
were determined by ELISA in BV2 microglial supernatants after H/R (4 h/24 h). Upregulated levels of (E) IL-6 (9 repeats), (F) TNF-α (8 repeats), and (G) IL-1β (8
repeats) after H/R were decreased and downregulated levels of (H) IL-10 (5 repeats) were upregulated by inhibition of ASK1 in BV2 microglial supernatants. Values
are mean ± SD. Statistical comparisons between the groups were assessed with non-parametric Mann–Whitney test (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs.
H/R). Statistical parameter (Supplementary Table 2). H/R, hypoxia/reperfusion.
FIGURE 5 | Downregulated pro-inflammatory cytokines and upregulated anti-inflammatory cytokines after inhibition of ASK1 in cultured RAW264.7 macrophage cell
line and supernatants. The levels of pro-inflammatory mediators such as (A) IL-6, (B) TNF-α, and (C) IL-1β and the anti-inflammatory mediator (D) IL-10 were
determined by ELISA in RAW 264.7 cell line after H/R (4 h/24 h). Increased (A) IL-6 (6 repeats), (B) TNF-α (5 repeats), and (C) IL-1β (6 repeats) levels after H/R were
decreased and (D) IL-10 (5 repeats) levels were increased by inhibition of ASK1 in RAW264.7 cell line. The levels of (E) IL-6, (F) TNF-α, and (G) IL-1β, and the
anti-inflammatory mediator (H) IL-10 were determined by ELISA in RAW264.7 supernatants after H/R (4 h/24 h). Augmented (A) IL-6 (6 repeats), (B) TNF-α (6
repeats), and (C) IL-1β (6 repeats) levels after H/R were diminished and (D) IL-10 (6 repeats) levels were increased by inhibition of ASK1 in RAW264.7 supernatants.
Values are mean ± SD. Statistical comparisons between the groups were assessed with non-parametric Mann–Whitney test (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001
vs. H/R). Statistical parameter (Supplementary Table 2). H/R, hypoxia/reperfusion.
Frontiers in Molecular Neuroscience | www.frontiersin.org 8 August 2017 | Volume 10 | Article 261
fnmol-10-00261 August 10, 2017 Time: 16:9 # 9
Cheon et al. Effects of ASK1 on Microglia/Macrophage
FIGURE 6 | Changes in M1 and M2 specific genes after inhibition of ASK1 in BV2 microglia cell line. The mRNA levels of M1 specific markers, such as (A) IL-1β (5
repeats), (B) iNOS (6 repeats), (C) TNF-α (5 repeats), and (D) CXCL10 (6 repeats), and M2 specific markers, such as (E) IL-10 (5 repeats), and (F) Ym-1 (4-5
repeats), were measured by real-time PCR in BV2 cell line after H/R (4 h/24 h). Increased mRNA levels of (A) IL-1β, (B) iNOS, (C) TNF-α, and (D) CXCL10 were
downregulated, while (E) IL-10 and (F) Ym-1 levels were increased by inhibition of ASK1 in BV2 cell line. Values are mean ± SD. Statistical comparisons between the
groups were assessed with non-parametric Mann–Whitney test (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs. H/R group). Statistical parameter (Supplementary Table 3).
H/R, hypoxia/reperfusion.
polarization-related factors such as IL-10 and Ym-1 showed
no significant difference (Figures 6E,F). After treatment with
NQDI-1 drug, mRNA levels of IL-1β, iNOS, TNF-α, and
CXCL10 were all efficiently downregulated despite H/R injury
(Figures 6A–D). The expression of M2-related factors including
IL-10 and Ym-1 were remarkably higher in ASK1-inhibited
BV2 microglia cell line (Figures 6E,F). Selected expression
of M1 and M2 phenotypes was quantified by real-time PCR
in RAW 264.7 macrophage cell line (Figure 7). As in the
case of cytokine expression using ELISA, H/R induced mRNA
levels of IL-1β, TNF-α, iNOS, and CXCL10 in macrophage cell
line (Figures 7A–D). Treatment with NQDI-1 drug efficiently
decreased mRNA levels of iNOS. Further, ASK1 inhibition
induced anti-inflammatory IL-10 and Ym-1 mRNA levels,
whereas H/R injury triggered M1-polarization (Figures 7E,F).
Therefore, our data suggested that inhibition of ASK1 promotes
BV2 microglia and RAW 264.7 macrophage cell lines toward M2
polarization after H/R injury. Statistical parameters were shown
in Supplementary Table 3.
Inhibition of ASK1 Increases M2
Phenotype of Microglia and
Macrophages
To confirm the expression of cell surface markers, we performed
flow cytometry using BV2 microglia and RAW 264.7 macrophage
cell lines. In this study, CD40 and CD206 were used as
M1 and M2 markers, respectively (Figure 8). In BV2 cells,
histograms showed that the expression of the M1 marker
CD40 was highly present after H/R injury. However, NQDI-1
drug treatment reduced the expression of CD40-positive cells
after H/R (Figure 8A). In the analysis of M2 phenotype, M2
marker (CD206-positive cells) was significantly increased on
NQDI-1 drug treatment (Figure 8B). Moreover, in RAW 264.7
cells, histograms revealed higher counts of CD40-positive cells
after H/R challenge, whereas inhibition of ASK1 decreased
CD40-positive cell counts despite H/R injury (Figure 8C).
In contrast, after suppression of ASK1 with NQDI-1 drug,
the expression of CD206-positive cells was higher in the
H/R stimulated RAW 264.7 cell line (Figure 8D). Statistical
parameters were shown in Supplementary Table 3.
Microglia and Macrophage
Hyper-Activation Is Reduced after
Inhibition of ASK1
To analyze cell migration, we performed gap closure assay
in cultured BV2 microglia and RAW 264.7 macrophage cell
lines (Figure 9). Before H/R injury, we made a gap with a
pipette tip, and cell debris was washed away with DPBS. We
observed BV2 microglia cell line under a microscope immediately
after H/R injury and at 24 h after H/R injury (Figure 9A).
H/R injury increased migration rates of BV2 microglia cell
line. However, inhibition of ASK1 reduced migration rates
(Figure 9B). The same methods were used in RAW 264.7
macrophage cell culture. We observed RAW 264.7 cell line
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FIGURE 7 | Changes in M1 and M2 specific genes after inhibition of ASK1 in RAW264.7 macrophage cell line. The mRNA levels of M1 specific markers, such as
(A) IL-1β (6 repeats), (B) iNOS (4–5 repeats), (C) TNF-α (4 repeats), and (D) CXCL10 (6 repeats), and M2 specific markers, such as (E) IL-10 (4 repeats) and
(F) Ym-1 (5–6 repeats), were measured by real-time PCR in RAW264.7 cell line after H/R (4 h/24 h). The mRNA levels of (A) IL-1β, (B) iNOS, (C) TNF-α, and
(D) CXCL10 were upregulated after H/R. The levels of iNOS were reduced, while (E) IL-10 and (F) Ym-1 levels were upregulated by inhibition of ASK1 in RAW264.7
cell line. Values are mean ± SD. Statistical comparisons between the groups were assessed with non-parametric Mann–Whitney test (∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001 vs. H/R). Statistical parameter (Supplementary Table 3). H/R, hypoxia/reperfusion.
under a microscope right after H/R injury and at 24 h after
H/R injury (Figure 9C). A high rate of migration was exhibited
in H/R-injured macrophages; however, NQDI-1 drug treatment
retarded the migration rate. Therefore, ASK1 is associated
with microglia and macrophage migration capacity and ASK1
inhibition delayed migration rate. Statistical parameters were
shown in Supplementary Table 3.
DISCUSSION
In this study, we performed in vivo and in vitro ischemic
stroke model to examine whether ASK1 modulates
microglia/macrophage polarization and function. We
proved that ASK1 controls polarization and function of
microglia/macrophage after ischemic/hypoxic injury. In
previous reports, ASK1 is one of the early responders to different
types of stress in the intracellular system, including oxidative
stress, calcium overload, and immune response (Hayakawa
et al., 2006; Takeda et al., 2008). ASK1 governs activation
of mitogen-activated protein kinase (MAP kinase), which is
essential for cellular function (Shiizaki et al., 2013), and several
studies support that ASK1 is closely related to cerebral ischemia
(Kim et al., 2011; Cheon et al., 2016b). Under inflammatory
conditions, ASK1 signaling is necessary for TLRs, which
recognize LPS (Soga et al., 2012). ASK1 deficiency represents LPS
resistance, and genetic deletion of ASK1 involves inhibition of
pro-inflammatory mediator production (Matsukawa et al., 2004;
Sumbayev, 2008; Takeda et al., 2008; Mnich et al., 2010). The
ASK1/p38 signaling pathway via TLRs is critical for chemokine
production and promotes inflammation and neurotoxicity
after multiple sclerosis (Guo et al., 2010). In line with studies
that have demonstrated that ASK1 inhibition attenuates
pro-inflammatory cytokines in microglia, ASK1 was found to
be associated with TNF-α and iNOS production in primary
microglial cell culture, and M1 macrophage suppression by a
Class A scavenger receptor resulted in reductions of IL-6, IL-1β,
and TNF-α, decreasing ASK1/p38/NF-κB pathway signaling,
under pathologic conditions (Hu et al., 2011; Katome et al.,
2013; Song and Lee, 2015). Previous reports have shown that
inhibition of ASK1 reduces M1 phenotype after injury and
ASK1 also played a role in our results. The main findings of
this study are (1) in the ipsilateral hemisphere, ASK1 silencing
resulted in a reduction of ischemic-induced activation of
microglia/infiltrated macrophages and increased M2 phenotype
in the late phase of cerebral ischemia and (2) ASK1 inhibition
polarized BV2 microglia and RAW 264.7 macrophage cell lines
toward M2 phenotype after hypoxia/reperfusion injury. Our
in vivo study revealed that cerebral ischemia promotes activation
of microglia and infiltration of macrophages in brain regions.
In the ipsilateral hemisphere, upregulation of pro-inflammatory
cytokines, such as IL-6, TNF-α, and IL-1β, was observed.
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FIGURE 8 | Alteration of M1 and M2 surface markers after inhibition of ASK1 in BV2 microglia and RAW264.7 macrophages. Flow cytometry was performed for
discrimination of (A) M1 (CD40) or (B) M2 (CD206) positive cell populations of BV2 cell line after H/R (4 h/24 h). The histogram of flow cytometry shows (C) M1
(CD40) and (D) M2 (CD206) positive cells in RAW 264.7 cell line after H/R (4 h/24 h). H/R, hypoxia/reperfusion.
However, ASK1 silenced by siRNA downregulated activation
of microglia/macrophage and pro-inflammatory cytokine
levels and upregulated the anti-inflammatory mediators. Our
in vitro study for M1/M2 polarization of microglia/macrophages
revealed that hypoxic injury stimulates M1-related factors,
while ASK1 inhibition by NQDI-1 drug suppressed M1-related
factors and promoted M2-related factors in microglia and
macrophage cell lines. In addition, inhibition of ASK1 retarded
the migration rate of both microglia and macrophages in gap
closure assay.
Inflammation has emerged as the key factor in progression
of ischemic stroke, and the inflammatory mediators play an
important role in enlargement of brain damage and neurological
dysfunction (Matsukawa et al., 2004; Quan and Banks, 2007;
Quan, 2008; Banks and Erickson, 2010; Fu et al., 2015;
Anrather and Iadecola, 2016). At the onset of ischemic stroke,
stagnant blood flow initiates an aberrant immune response that
promotes infiltration of immune cells such as leukocytes and
macrophages, via a disrupted BBB (Matsukawa et al., 2004;
Quan and Banks, 2007; Quan, 2008; Banks and Erickson,
2010; Fu et al., 2015; Anrather and Iadecola, 2016). Under
the altered environment, microglia are activated. Meanwhile,
the morphology and activation of peripherally infiltrated
macrophages in the brain changes depending on the extracellular
stimuli (Durafourt et al., 2012; Hu et al., 2015; Orihuela
et al., 2016), after which activated microglia migrate quickly
toward lesion sites, and lead to cell accumulation by releasing
inflammation-associated mediators (Danton and Dietrich, 2003).
Based on the microenvironment, microglia/macrophage can
switch between phenotypes M1 (classically activated) and
M2 (alternative activated). Under M1 conditions stimulated
by LPS or IFN-γ, M1 microglia/macrophage express pro-
inflammatory mediators of IL-1β, IL-6, TNF-α, iNOS, and
CXCL10 and the cell surface markers CD40, CD80, and
CD86. Also, cytotoxic effects of the M1 phenotype can
exacerbate tissue damage (Durafourt et al., 2012; Hu et al.,
2015; Kapellos and Iqbal, 2016; Orihuela et al., 2016; Plastira
et al., 2016). On the contrary, M2 microglia/macrophages exert
anti-inflammatory responses by upregulating IL-10, arginase-1,
Ym-1 (heparin-binding lectin), and mannose receptor CD206,
which modulate tissue repair, regeneration, and remodeling
(Durafourt et al., 2012; Barakat and Redzic, 2016; Orihuela
et al., 2016). During the early stage after ischemic insult,
expression of the pro-inflammatory cytokine TNF-α is increased
in neurons. However, during the late phase of ischemic insult,
it is augmented in microglia/macrophage and other immune
cells, with microglia/macrophage being major sources of pro-
inflammatory cytokine in ischemic lesions after ischemic stroke
(Gregersen et al., 2000; Clausen et al., 2008). Late inflammation
in the brain after ischemic stroke is represented by persistent
immune cell infiltration and cerebral infarctions (Mena et al.,
2004; Brea et al., 2009; Vogelgesang et al., 2014; Walter et al.,
2015; Anrather and Iadecola, 2016). Several studies have reported
that microglia/macrophage shift their phenotype from M2
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FIGURE 9 | Function of BV2 microglia and RAW264.7 macrophages after inhibition of ASK1. (A,B) Gap closure assay was performed for BV2 and RAW264.7 cells
(A) Images at 0 h after hypoxia and 24 h after hypoxia/reperfusion in BV2 cell line. (B) The graph represents that H/R-induced increases in migration rate were
decreased by inhibition of ASK1 in BV2 cell line (4 repeats). (C) Images at 0 h after hypoxia and 24 h after hypoxia/reperfusion in RAW264.7 cell line. (D) The graph
represents that H/R-induced increases in migration rate were reduced by inhibition of ASK1 in RAW264.7 cell line (4 repeats). Values are mean ± SD. Statistical
comparisons between the groups were assessed with non-parametric Mann–Whitney test (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs. H/R). Statistical parameter
(Supplementary Table 3). H/R, hypoxia/reperfusion.
to M1 after cerebral ischemia and M1 microglia/macrophage
dominate the ischemic lesion in the brain, which exacerbate
brain injury (Frieler et al., 2011; Hu et al., 2012). M1
polarized microglia/macrophage during chronic inflammation
augment neuronal damage and block reestablishment of
neuronal network, thereby retarding brain recovery (Hu et al.,
2012). However, M2 polarized microglia/macrophage show
improved phagocytic activity for clearance of necrotic debris
and ameliorate production of inflammatory mediators (Hu
et al., 2012). M2 phenotype modifies the extracellular matrix
and promotes axonal regeneration and angiogenesis (Kigerl
et al., 2009). In addition, after ischemic/hypoxic insult, M2
microglia/macrophage mediates clearance of ischemic tissue
and blockade of brain injury, leading to neuronal survival
(Hu et al., 2012). Therefore, anti-inflammatory M2 may have
beneficial effects on ameliorating the development of brain
damage. In the current study, cerebral ischemia augmented
the recruitment of macrophage and microglia activation
and migration, and led the brain toward M1 environment.
However, ASK1 silencing by si-RNA/ASK1 inhibition by
NQDI-1 drug diminished M1 phenotype-specific markers
(secretion of pro-inflammatory mediators and downregulation
of pro-inflammatory mediator genes) of macrophage/microglia
and upregulated M2 specific markers (expression of anti-
inflammatory mannose receptor and upregulation of anti-
inflammatory mediator genes) in the later stages of the recovery
period after ischemic/hypoxic injuries. To our knowledge, this is
the first investigations of ASK1 in regards to M1/M2 polarization
of microglia and macrophages in the late stage of ischemic
stroke.
However, our limitations are as follows: first, it is not
clarified which ASK1-downstream or -related signaling pathway
affects M1/M2 phenotype. Although several molecules (JNK,
p38, and Akt) are known to be involved in polarization
(Zhang and Zhang, 2015; Vergadi et al., 2017; Zhong et al.,
2017), we only proceeded to examine changes of M1/M2
phenotype by silencing/inhibiting ASK1 levels. Second,
we focused on “classical” M1/M2 polarization in this
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study. However, Martinez et al. (2008) and Mantovani et al.
(2004) review the subpopulation of polarization, such as M1,
M2a, M2b, and M2c. Ransohoff (2016) raises some concerns
on existence of M1/M2 polarization (Mantovani et al., 2004;
Martinez et al., 2008). Third, the previous studies proved that
ASK1 inhibitor NQDI-1 shows a possible therapeutic application
as a protective drug in ischemic stroke (Song et al., 2015;
Cheon et al., 2016a). However, it is not fully demonstrated
its safety and application. If this limitation is resolved, it
will be one of the candidates for use in ischemic stroke
patients.
CONCLUSION
We showed that ASK1 mediates M1/M2 polarization and
the functions of microglia and macrophages. Modulation of
the late inflammatory environment by M1/M2 regulation of
microglia and macrophage via ASK1 silencing after cerebral
ischemia may be an attractive strategy for recovery from
stroke.
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